Nosopharm
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $4.6M
Investors
- 3
About Nosopharm
Founded in 2009 and based in Nimes, France, Nosopharm SAS is a biotechnology company that develops new molecules to combat bacteria and pathogens with multiple drug resistance.
Who invested in Nosopharm
3 investors across 2 rounds
See all investors in Nosopharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nosopharm
Who invested in Nosopharm?
Nosopharm has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nosopharm raised?
Nosopharm has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nosopharm last raise money?
Nosopharm's most recent round on record is a Series B, in Sep 2020.
What does Nosopharm do?
Founded in 2009 and based in Nimes, France, Nosopharm SAS is a biotechnology company that develops new molecules to combat bacteria and pathogens with multiple drug resistance.
Where is Nosopharm headquartered?
Nosopharm is headquartered in Nimes, France.
Which VCs invest in companies like Nosopharm?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Nosopharm's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nosopharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.